ep seen high-
end guidanc
follow earn call rais oper ep
estim estim
reflect out-performance quarter driven continu strength
profit within japanes us oper lower tax rate
benefit higher interest rate reiter hold rate lower
price previous repres book
valu per share estim slight premium peer group
report oper ep ahead estim
equal street mean total revenu billion
year-ago quarter driven higher net invest incom aflac us
y/i aflac japan gain fraction weaker
yen quarter versu year ago materi
impact effect tax rate came estim
benefit million favor tax item yield extra penni
ep book valu per share quarter-end
aflac japan record net premium incom billion
year-over-year billion forecast said
manag remain enthusiast regard introduct new cancer
insur product earlier year bolster compani distribut
channel consequ third sector sale growth line
expect off-set declin first sector premium account
two-third sale quarter year ago period
manag project call similar growth continu
expect low single-digit growth product categori full-year
remind out-performance top strong sale result
introduct medic product
aflac japan benefit ratio rel line
guidanc basi point similar
basi point declin seen last quarter slightli
estim altern expens ratio
manag expect expens ratio
japan experienc favor claim trend shift
busi mix lend lower benefit ratio higher expens ratio
conjunct new product introduct aflac japan launch
target promot campaign televis ad
tr target
thru includ hedg cost
compani report hedg cost within oper
earn start restat prior period
reflect account chang
largest direct mail campaign compani histori second
quarter shift much new busi second quarter
limit follow-through
ask rel soft medic product sale
manag point mani new compani come medic
insur market lower rate new product offer
aflac us premium incom advanc billion match forecast total new
premium million better year-ago quarter outpac recruit agent count
growth segment report net invest incom million
prior-year period manag optimist regard growth us particularli
relat broker sale group product although recruit remain challeng product
improv develop exist account agent train said compani
expect annual premium sale growth come lower end rang
us benefit ratio basi point prior-year period miss
estim basi point expens ratio came basi point greater
though manag attribut time issu bulk expect
spend digit initi fund tax reform take place
manag expect benefit ratio roughli full year expens ratio
around influenc time invest ad spend
segment margin declin attribut partli mix shift busi cancer
in-forc book busi becom lower percentag total in-forc group
busi put pressur lower margin higher expens profil said
manag believ new cancer product catch busi
come lap reissu
given out-performance quarter manag expect full-year ep
high-end rang note last quarter compani increas
rang previou guidanc assum weight averag exchang
rate yen per dollar chang quarter manag continu anticip
billion billion share repurchas year includ million deploy quarter
quarter-end manag estim us approxim includ
impact tax reform reduc ratio around basi point manag
also expect year-end roughli anticip last quarter
remain basi point come combin ordinari dividend
underwrit subsidiari hold compani million drawdown excess
page
consolid benefit expens
benefit claim
revenu
acquisit oper expens
amort defer polici acquisit cost
revenu
total acquisit oper expens
revenu
total benefit expens
revenu
corpor elimin
updat
requir disclosur last tab workbook
compani file suntrust robinson humphrey estim
price
page
subsidiari engag market sale supplement health
life insur unit state japan offer variou insur product japan
includ plan cancer life gener medic indemn medical/sick rider care live benefit
life ordinari life insur annuiti compani provid unit state plan
accident/dis cancer expens short-term disabl sick hospit indemn hospit
intens care fixed-benefit dental vision care long-term care well life insur product
underwrit individu issu polici market polici independ agent well
independ corporate/individu agenc affili corpor agenc compani
found headquart columbu georgia
believ risk reward own share fairli balanc compani
strong franchis core market opportun grow especi via
partnership japan howev sale growth key product choppi
valuat appear fair rel peer
valuat risk
price target price target bvp forecast book valu basi
share trade slight premium life insur compani averag
book believ valuat appropri light compani solid return equiti
look expans measur
risk rate price target compani may exceed price target sale growth re-
acceler come quarter beyond current expect lower claim cost boost report
earn hand deterior yen relat japanes monetari eas may
lead contract report ep may deter investor
mark hugh herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
